Ripretinib (DCC-2618)
CAS: 1442472-39-0
Ref. 3D-SHC47239
| 1mg | Discontinued | ||
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
Ripretinib (DCC-2618)
Description:
Ripretinib is a potent, orally bioavailable inhibitor of the tyrosine kinase activity of RET. It has been shown to be effective in treating gastrointestinal cancer and solid tumours. This drug is metabolized by cytochrome P450 (CYP) enzymes and interacts with other drugs that are CYP substrates. Ripretinib also inhibits the activity of other cellular factors, such as cell factor (CF), which may contribute to its antitumour effects.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
510.36 g/mol
Formula:
C24H21BrFN5O2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
